MELISSA EMMERLING: Open Payments
NPI 1780647305 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$594 in 10 payments from 6 companies in 2025. Trend: 2023 $30 · 2024 $144 · 2025 $594
Food & beverage: $594
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $265 |
| Mallinckrodt Hospital Products Inc. | 1 | $117 |
| Gilead Sciences, Inc. | 3 | $105 |
| Ipsen Biopharmaceuticals, Inc | 2 | $48 |
| Veloxis Pharmaceuticals, Inc. | 1 | $39 |
| ABBVIE INC. | 1 | $20 |
Products named: REZDIFFRA, TERLIVAZ, IQIRVO, ENVARSUS, LINZESS.
Industry payments across FL — which companies pay providers there.
